未登录
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏Natural lignocellulosic biomass structure inspired CNF/Lignin/PBAT composite film with thermoplastic, antibacterial and UV-blocking abilities
Chen, Jiahua; Chen, Xinyi; Zhang, Baoquan; He, Li; Li, Xinjian; Li, Yingzhan; Zhang, Zhen; Zhou, Ying; Jin, Wanhui; He, Xia; Liu, Hongchen
分享
收藏
分享
收藏
分享
收藏An analysis of differences in Carbapenem-resistant Enterobacterales in different regions: a multicenter cross-sectional study
Guo, Bo; Li, Peili; Qin, Bingyu; Wang, Shanmei; Zhang, Wenxiao; Shi, Yuan; Yang, Jianxu; Niu, Jingjing; Chen, Shifeng; Chen, Xiao; Cui, Lin; Fu, Qizhi; Guo, Lin; Hou, Zhe; Li, Hua; Li, Xiaohui; Liu, Ruifang; Liu, Xiaojun; Mao, Zhengrong; Niu, Xingguo; Qin, Chao; Song, Xianrong; Sun, Rongqing; Sun, Tongwen; Wang, Daoxie; Wang, Yong; Xu, Lanjuan; Xu, Xin; Yang, Yuejie; Zhang, Baoquan; Zhou, Dongmin; Li, Zhaozhen; Chen, Yinyin; Jin, Yue; Du, Juan; Shao, Huanzhang
分享
收藏
分享
收藏ZnFexAl2-xO4 spinel supported PdZnβ bifunctional catalyst for methanol steam reforming
Zhang, Lina; Wang, Jianhuang; Zhang, Baoquan; Lin, Zenan; Liu, Lele; Zhang, Xianhua; Wang, Shuai; Lin, Jingdong; Xiong, Haifeng; Wu, Chuanqiang; Wang, Yong; Wan, Shaolong
分享
收藏TQB2450 (PD-L1 blockade) in combination with anlotinib as a perioperative treatment for patients with hepatocellular carcinoma at high risk of recurrence: Primary results from a prospective, single-arm, phase Ib study
Huang, Z.; Zhou, J.; Yang, M.; Zhang, W.; Sun, Y.; Lu, H.; Wang, H.; Bi, X.; Zhang, Y.; Zhao, J.; Yang, Y.; Zhang, B.; Ye, F.; Zhao, H.
分享
收藏
分享
收藏Efficacy and safety of sintilimab in combination with anlotinib plus metronomic chemotherapy in advanced triple-negative breast cancer (SPACE): Preliminary results of a single-arm, multicenter phase II trial
Li, H.; Zhou, D.; Yv, Z.; Liao, Y.; Huang, J.; Sun, S.; Zheng, F.; Li, B.; Fang, S.; Qiang, L.; Ren, G.; Wang, X.; Zhang, B.; Fan, B.; Zhao, X.; Li, W.; Wang, Z.; Fu, H.; Sun, X.; Shi, Z.
分享
收藏Neoadjuvant QL1209 (a pertuzumab biosimilar) compared with pertuzumab plus trastuzumab and docetaxel in early or locally advanced, HER2-positive, ER(-)/PR(-) breast cancer: A multicenter, randomized, double-blind, equivalence, phase III study
Shao, Z.; Zhang, J.; Qian, J.; Ma, X.; Niu, Z.; Ou, J.; Mo, Q.; Sun, J.; Li, X.; Wang, Q.; Yao, Y.; Yu, G.; Li, H.; Chen, D.; Zhang, H.; Geng, C.; Qiao, G.; Zhao, M.; Zhang, B.; Kang, X.
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏
分享
收藏